CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference on Monday, May 14, 2007, at 10:05 a.m. CEST (4:05 a.m. ET) at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
